French pharmaceutical giant Sanofi and American drugmaker Regeneron said Monday they have started clinical trials for a new drug in patients hospitalised with severe COVID-19 infections.
Read More
French pharmaceutical giant Sanofi and American drugmaker Regeneron said Monday they have started clinical trials for a new drug in patients hospitalised with severe COVID-19 infections.
Read More
Health Rss 